Otros idiomas Hubei Guangji Pharmaceutical Co., Ltd.

Acciones

000952

CNE0000010R5

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 31/05/2024			Varia. Cinco días.	Varia. 1 de enero.
5,78 ^CNY	+0,87 %		-3,99 %	-27,66 %

25/04	Hubei Guangji Pharmaceutical Co. Ltd. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
25/04	Hubei Guangji Pharmaceutical Co. Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04
Guangji Pharmaceutical Gets Nod to Produce Entecavir	07/11
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University	15/06/23
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals	17/05/23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022	20/04/23
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/04/23
Guangji Pharma Registers Diabetes-Related Infection Drug	29/03/23
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization	08/02/23
Hubei Guangji Pharma Signs 6MW Solar Power Project	15/12/22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage	04/10/22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/08/22
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022	19/05/22
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	21/04/22
Hubei Guangji Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Year 2021	25/03/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Hubei Guangji Pharmaceutical Co., Ltd.

Acciones

000952

CNE0000010R5

Otros idiomas

Filtros